9th Jul 2015 08:28
LONDON (Alliance News) - Venture Life Group PLC on Thursday said its first half revenue is in line with market expectations and said it is encouraged by current trading trends.
The company, which makes products for the ageing population, said it signed three long-term distribution deals in the first half and said it has secured its first purchase order for skin-care products under its deal with Chinese partner Gialen. As a result, the company has received a EUR0.52 upfront payment for the first half of the order.
The group added it has developed four new products for its Vonalei women's health range, with the first set to be launched in early 2016. Two further medical devices were also developed in the first half, with one to be launched in October and the other under clinical evaluation.
"I am pleased at how well the now integrated group is progressing, with trading in line with our growth expectations. Every part of the business is working well and contributing, and through our investment in new people and plant equipment, we expect to continue this accelerated rate of growth," said Jerry Randall, chief executive of Venture Life.
Shares in Venture Life were untraded on Thursday, having last traded at 88.00 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Venture Life